Deep understanding of the interaction between thienorphine and UDP-glucuronosyltransferase (UGT) isoforms

References

• Dong RH, Fang ZZ, Zhu LL, Liang SC, Ge GB, Yang L, Liu ZY. (2012a). Investigation of UDP-glucuronosyltransferases (UGTs) inhibitory properties of carvacrol. Phytother Res 26:86–90.
   PubMed Web of Science ®Google Scholar
• Dong RH, Fang ZZ, Zhu LL, Ge GB, Yang L, Liu ZY. (2012b). Identification of UDP-glucuronosyltransferase isoforms involved in hepatic and intestinal glucuronidation of phytochemical carvacrol. Xenobiotica. doi: 10.3109/00498254.2012.682614.
   Google Scholar
• Fang ZZ, Zhang YY, Ge GB, Huo H, Liang SC, Yang L. (2010). Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction. Br J Clin Pharmacol 69:193–199.
   PubMed Web of Science ®Google Scholar
• Fang ZZ, Zhang YY, Wang XL, Cao YF, Huo H, Yang L. (2011a). Bioactivation of herbal constituents: simple alerts in the complex system. Expert Opin Drug Metab Toxicol 7:989–1007.
   PubMed Web of Science ®Google Scholar
• Fang ZZ, Zhang YY, Ge GB, Liang SC, Sun DX, Zhu LL, Dong PP, Cao YF, Yang L. (2011b). Identification of cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline, and assessment of its herb-drug interactions. Phytother Res 25:256–263.
   PubMed Web of Science ®Google Scholar
• Huang T, Fang ZZ, Yang L. (2010). Strong inhibitory effect of medroxyprogesterone acetate (MPA) on UDP-glucuronosyltransferase (UGT) 2B7 might induce drug-drug interactions. Pharmazie 65:919–921.
   PubMed Web of Science ®Google Scholar
• Innocenti F, Iyer L, Ratain MJ. (2001). Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan. Drug Metab Dispos 29:596–600.
   PubMed Web of Science ®Google Scholar
• Kiang TK, Ensom MH, Chang TK. (2005). UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther 106:97–132.
   PubMed Web of Science ®Google Scholar
• Kong Q, Qiao J, Wang X, Yuan S, Zhang Z, Gong Z, Ruan J. (2007). Simultaneous determination of thienorphine and its active metabolite thienorphine glucuronide in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci 859:52–61.
   PubMedGoogle Scholar
• Lewis JW. (1985). Buprenorphine. Drug Alcohol Depend 14:363–372.
   PubMed Web of Science ®Google Scholar
• Liu CH, Liu H, Han XY, Wu B, Zhong BH, Gong ZH. (2005). Synthesis and characterization of thienorphine and its glucuronide conjugate. Synthetic Communications 35:701–710.
   Google Scholar
• Liu Y, Ramírez J, Ratain MJ. (2011). Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors. Br J Clin Pharmacol 71:917–920.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275.
   PubMed Web of Science ®Google Scholar
• Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, Nebert DW. (2005). Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677–685.
   PubMed Web of Science ®Google Scholar
• Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, Yokoi T. (2008). Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36:1461–1464.
   PubMed Web of Science ®Google Scholar
• Qu YQ, Fang ZZ, Yang L, Gao ZM, Liang R, Zhu LL, Dong PP, Zhang YY, Ge GB, Wang LM. (2011). Reversible inhibition of four important human liver cytochrome P450 enzymes by diethylstilbestrol. Pharmazie 66:216–221.
   PubMedGoogle Scholar
• Ritter JK. (2000). Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem Biol Interact 129:171–193.
   PubMed Web of Science ®Google Scholar
• Sun DX, Fang ZZ, Zhang YY, Cao YF, Yang L, Yin J. (2010). Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes. Phytother Res 24:1213–1216.
   PubMed Web of Science ®Google Scholar
• Uchaipichat V, Mackenzie PI, Elliot DJ, Miners JO. (2006). Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) “probes” for human udp-glucuronosyltransferases. Drug Metab Dispos 34:449–456.
   PubMed Web of Science ®Google Scholar
• Yu G, Yue YJ, Cui MX, Gong ZH. (2006). Thienorphine is a potent long-acting partial opioid agonist: a comparative study with buprenorphine. J Pharmacol Exp Ther 318:282–287.
   PubMed Web of Science ®Google Scholar
• Zhou J, Tracy TS, Remmel RP. (2011). Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitors. Drug Metab Dispos 39:322–329.
   PubMed Web of Science ®Google Scholar
• Zhu LL, Ge GB, Zhang HB, Liu HX, He GY, Liang SC, Zhang YY, Fang ZZ, Dong PP, Finel M, Yang L. (2012a). Characterization of hepatic and intestinal glucuronidation of magnolol: application of the RAF approach to decipher the contributions of multiple UGT isoforms. Drug Metab Dispos 40:522–528.
   PubMedGoogle Scholar
• Zhu LL, Ge GB, Liu Y, He GY, Liang SC, Fang ZZ, Dong PP, Cao YF, Yang L. (2012b). Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9. Xenobiotica, DOI:10.3109/00498254.2012.681814.
   Google Scholar
• Zimmerman DM, Leander JD. (1990). Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents. J Med Chem 33:895–902.
   PubMed Web of Science ®Google Scholar